DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Press-release

Decision Resources Study on Post-Myocardial Infarction Finds AstraZeneca's Rosuvastatin May Become the Statin of Choice by 2005

Decision Resources Study on Post-Myocardial Infarction Finds AstraZeneca's Rosuvastatin May Become the Statin of Choice by 2005

Post-Myocardial Infarction is a new study from Decision Resources, Inc., that examines how the need for better and novel cardioprotective agents to...

READ ARTICLE

Press-release

Novel Asthma Therapies and Combination Agents Will Vie for Market Share, According to a Decision Resources Study

Novel Asthma Therapies and Combination Agents Will Vie for Market Share, According to a Decision Resources Study

Asthma is a new Decision Resources study that examines novel drug development efforts arising from a wealth of research into the pathophysiology of...

READ ARTICLE